Macomics
PrivateLast Round
Seed
Jul 29, 2021
Total Funding Raised
$9.97M
Company Overview
Macomics is a biotechnology company developing precision medicines designed to modulate macrophages for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Macomics Comparables
Compare Macomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verseau Therapeutics | 78% | |
| United Immunity, Co., Ltd. | 78% | |
| LTZ Therapeutics | 76% | |
Macomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 29, 2021 | ||||
| Seed | Jul 14, 2020 |
Macomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Epidarex Capital | Seed |
| Old College Capital | Seed |
| Scottish Investment Bank (Scottish Enterprise) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2025
Monthly visitors increased 347% MoM.
- Jul 29, 2021
$6M raised in Seed round.
Macomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Macomics's valuation, stock price, and market status.